항콕시듐제 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 약제클래스별, 작용기서별, 동물 유형별, 유통경로별, 지역별, 경쟁별 세분화(2020-2030년)
Anticoccidial Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast Segmented By Drug Class, By Drug Action, By Animal Type, By Distribution Channel By Region and Competition, 2020-2030F
상품코드:1886350
리서치사:TechSci Research
발행일:2025년 12월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 항콕시듐제 시장은 2024년에 14억 1,000만 달러로 평가되며, 2030년까지 CAGR 3.96%로 성장하며, 17억 8,000만 달러에 달할 것으로 예측됩니다. 항콕시듐제는 주로 가축, 특히 가금류의 장에 영향을 미치는 기생충 질환인 콕시듐증을 예방하고 치료하기 위해 개발된 의약품입니다. 이 질병은 원생 동물의 *Eimeria* 속이 원인입니다. 시장의 성장은 근본적으로 동물성 단백질에 대한 전 세계 수요 증가에 의해 지원되고 있으며, 이는 집약적인 축산 방식으로 이어져 콕시듐증 발생률을 증가시키고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
14억 1,000만 달러
시장 규모 : 2030년
17억 8,000만 달러
CAGR : 2025-2030년
3.96%
가장 빠르게 성장하는 부문
반려 동물
최대 시장
북미
주요 시장 성장 촉진요인
세계 항콕시듐제 시장은 가축과 가금류의 콕시듐증 발병률 증가와 동물성 단백질에 대한 세계 수요 증가에 힘입어 크게 성장하고 있습니다. *Eimeria 원충에 의한 콕시듐증의 광범위한 특성으로 인해 동물의 건강과 생산성을 유지하기 위해 효과적인 의약품 개입이 지속적으로 필요합니다.
주요 시장 과제
약제 내성 콕시듐 균주의 지속적인 발생은 세계 항콕시듐제 시장의 성장에 심각한 장벽이 되고 있습니다. 이러한 광범위한 문제는 기존 약물 치료의 효과를 직접적으로 저해하는 것으로, 새로운 화합물 및 치료 전략 개발을 위한 끊임없는 혁신과 연구개발에 대한 막대한 투자를 필요로 합니다.
주요 시장 동향
잔류물 없는 동물성 제품에 대한 소비자 수요 증가와 약제 내성 문제에 대응해야 하는 업계의 필요성에 따라 자연 유래 및 프로바이오틱스를 기반으로 한 콕시듐증 관리로의 전환이 두드러진 추세입니다. 생산자들은 프로바이오틱스, 프리바이오틱스 등 사료첨가제를 적극적으로 도입하여 장내 환경을 건강하게 유지하고 동물의 자연 면역력을 향상시키기 위해 노력하고 있습니다.
목차
제1장 개요
제2장 조사 방법
제3장 개요
제4장 고객의 소리
제5장 세계의 항콕시듐제 시장 전망
시장 규모·예측
금액별
시장 점유율·예측
약제클래스별(이오노포어, 항생제, 술폰아미드, 화학 유도체, 기타 약제 클래스)
약제작용별(콕시듐 증식 억제제, 콕시듐 살균제)
동물 유형별(생산 동물, 반려 동물)
유통 채널별(동물병원, 소매 약국, 기타 유통 채널)
지역별
기업별(2024)
시장 맵
제6장 북미의 항콕시듐제 시장 전망
시장 규모·예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 항콕시듐제 시장 전망
시장 규모·예측
시장 점유율·예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 항콕시듐제 시장 전망
시장 규모·예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 항콕시듐제 시장 전망
시장 규모·예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 항콕시듐제 시장 전망
시장 규모·예측
시장 점유율·예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
촉진요인
과제
제12장 시장 동향과 발전
합병·인수
제품 출시
최근 동향
제13장 세계의 항콕시듐제 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
Vetoquinol SA
Zoetis Philippines Inc.
Phibro Animal Health Corporation
Huvepharma, Inc.
Elanco US Inc.
Biochem Pharmaceutical Industries Ltd
Ceva Sante Animale SA
Impextraco NV
Boehringer Ingelheim International GmbH
Merck & Co., Inc.
제16장 전략적 제안
제17장 조사회사 소개·면책사항
KSA
영문 목차
영문목차
The Global Anticoccidial Drugs Market, valued at USD 1.41 Billion in 2024, is projected to experience a CAGR of 3.96% to reach USD 1.78 Billion by 2030. Anticoccidial drugs are pharmaceutical agents developed to prevent and treat coccidiosis, a parasitic disease primarily impacting the intestinal tracts of livestock, particularly poultry, caused by protozoa of the genus *Eimeria*. The market's growth is fundamentally supported by the escalating global demand for animal protein, leading to intensive farming practices that increase coccidiosis incidence.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 1.41 Billion
Market Size 2030
USD 1.78 Billion
CAGR 2025-2030
3.96%
Fastest Growing Segment
Companion Animals
Largest Market
North America
Key Market Drivers
The global anticoccidial drugs market experiences significant expansion driven by the escalating prevalence of coccidiosis in livestock and poultry, coupled with a growing global demand for animal protein. The widespread nature of coccidiosis, caused by *Eimeria* protozoa, consistently necessitates effective pharmaceutical interventions to maintain animal health and productivity.
Key Market Challenges
The continuous development of drug-resistant coccidia strains presents a significant impediment to the growth of the Global Anticoccidial Drugs Market. This pervasive issue directly undermines the effectiveness of existing pharmaceutical treatments, necessitating constant innovation and substantial investment in research and development for novel compounds and treatment strategies. As existing drugs become less potent against evolved parasite strains, their market value and utility diminish, compelling manufacturers to shoulder considerable costs for developing new solutions. This prolonged and costly development cycle for effective new drugs, coupled with the shortened effective lifespan of current products due to resistance, directly stifles overall market expansion.
Key Market Trends
The shift towards natural and probiotic-based coccidiosis management represents a significant trend, driven by increasing consumer demand for residue-free animal products and the industry's need to address drug resistance challenges. Producers are increasingly incorporating feed additives, such as probiotics and prebiotics, to foster robust gut health and enhance the animals' natural immunity. This approach reduces reliance on conventional anticoccidial drugs.
Key Market Players
Vetoquinol SA
Zoetis Philippines Inc.
Phibro Animal Health Corporation
Huvepharma, Inc.
Elanco US Inc.
Biochem Pharmaceutical Industries Ltd
Ceva Sante Animale SA
Impextraco NV
Boehringer Ingelheim International GmbH
Merck & Co., Inc.
Report Scope:
In this report, the Global Anticoccidial Drugs Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Anticoccidial Drugs Market, By Drug Class:
Ionophore
Antibiotic
Sulphonamides
Chemical Derivative
Other Drug Classes
Anticoccidial Drugs Market, By Drug Action:
Coccidiostatic
Coccidiocidal
Anticoccidial Drugs Market, By Animal Type:
Production Animals
Companion Animals
Anticoccidial Drugs Market, By Distribution Channel:
Veterinary Hospitals
Retail Pharmacy
Other Distribution Channels
Anticoccidial Drugs Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Anticoccidial Drugs Market.
Available Customizations:
Global Anticoccidial Drugs Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Anticoccidial Drugs Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Drug Class (Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes)
5.2.2. By Drug Action (Coccidiostatic, Coccidiocidal)
5.2.3. By Animal Type (Production Animals, Companion Animals)
5.2.4. By Distribution Channel (Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Anticoccidial Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Class
6.2.2. By Drug Action
6.2.3. By Animal Type
6.2.4. By Distribution Channel
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Anticoccidial Drugs Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Drug Class
6.3.1.2.2. By Drug Action
6.3.1.2.3. By Animal Type
6.3.1.2.4. By Distribution Channel
6.3.2. Canada Anticoccidial Drugs Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Drug Class
6.3.2.2.2. By Drug Action
6.3.2.2.3. By Animal Type
6.3.2.2.4. By Distribution Channel
6.3.3. Mexico Anticoccidial Drugs Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Drug Class
6.3.3.2.2. By Drug Action
6.3.3.2.3. By Animal Type
6.3.3.2.4. By Distribution Channel
7. Europe Anticoccidial Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug Class
7.2.2. By Drug Action
7.2.3. By Animal Type
7.2.4. By Distribution Channel
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Anticoccidial Drugs Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Drug Class
7.3.1.2.2. By Drug Action
7.3.1.2.3. By Animal Type
7.3.1.2.4. By Distribution Channel
7.3.2. France Anticoccidial Drugs Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Drug Class
7.3.2.2.2. By Drug Action
7.3.2.2.3. By Animal Type
7.3.2.2.4. By Distribution Channel
7.3.3. United Kingdom Anticoccidial Drugs Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Drug Class
7.3.3.2.2. By Drug Action
7.3.3.2.3. By Animal Type
7.3.3.2.4. By Distribution Channel
7.3.4. Italy Anticoccidial Drugs Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Drug Class
7.3.4.2.2. By Drug Action
7.3.4.2.3. By Animal Type
7.3.4.2.4. By Distribution Channel
7.3.5. Spain Anticoccidial Drugs Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Drug Class
7.3.5.2.2. By Drug Action
7.3.5.2.3. By Animal Type
7.3.5.2.4. By Distribution Channel
8. Asia Pacific Anticoccidial Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug Class
8.2.2. By Drug Action
8.2.3. By Animal Type
8.2.4. By Distribution Channel
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Anticoccidial Drugs Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Drug Class
8.3.1.2.2. By Drug Action
8.3.1.2.3. By Animal Type
8.3.1.2.4. By Distribution Channel
8.3.2. India Anticoccidial Drugs Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Drug Class
8.3.2.2.2. By Drug Action
8.3.2.2.3. By Animal Type
8.3.2.2.4. By Distribution Channel
8.3.3. Japan Anticoccidial Drugs Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Drug Class
8.3.3.2.2. By Drug Action
8.3.3.2.3. By Animal Type
8.3.3.2.4. By Distribution Channel
8.3.4. South Korea Anticoccidial Drugs Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Drug Class
8.3.4.2.2. By Drug Action
8.3.4.2.3. By Animal Type
8.3.4.2.4. By Distribution Channel
8.3.5. Australia Anticoccidial Drugs Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Drug Class
8.3.5.2.2. By Drug Action
8.3.5.2.3. By Animal Type
8.3.5.2.4. By Distribution Channel
9. Middle East & Africa Anticoccidial Drugs Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Drug Class
9.2.2. By Drug Action
9.2.3. By Animal Type
9.2.4. By Distribution Channel
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Anticoccidial Drugs Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Drug Class
9.3.1.2.2. By Drug Action
9.3.1.2.3. By Animal Type
9.3.1.2.4. By Distribution Channel
9.3.2. UAE Anticoccidial Drugs Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Drug Class
9.3.2.2.2. By Drug Action
9.3.2.2.3. By Animal Type
9.3.2.2.4. By Distribution Channel
9.3.3. South Africa Anticoccidial Drugs Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Drug Class
9.3.3.2.2. By Drug Action
9.3.3.2.3. By Animal Type
9.3.3.2.4. By Distribution Channel
10. South America Anticoccidial Drugs Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Drug Class
10.2.2. By Drug Action
10.2.3. By Animal Type
10.2.4. By Distribution Channel
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Anticoccidial Drugs Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Drug Class
10.3.1.2.2. By Drug Action
10.3.1.2.3. By Animal Type
10.3.1.2.4. By Distribution Channel
10.3.2. Colombia Anticoccidial Drugs Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Drug Class
10.3.2.2.2. By Drug Action
10.3.2.2.3. By Animal Type
10.3.2.2.4. By Distribution Channel
10.3.3. Argentina Anticoccidial Drugs Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Drug Class
10.3.3.2.2. By Drug Action
10.3.3.2.3. By Animal Type
10.3.3.2.4. By Distribution Channel
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Anticoccidial Drugs Market: SWOT Analysis
